Regulatory and Washington

Press enter to search
Close search
Open Menu

Regulatory and Washington

Regulatory news and trends in retail pharmacies.

NACDS makes 3 executive moves

The National Association of Chain Drug Stores’ Chris Krese will lead congressional relations and communications, while Christie Boutte and Kathleen Jaeger will assume new policy and advocacy roles.

CHPA, CRN back bill that would create CBD, hemp framework

The Hemp and Hemp-Derived CBD Consumer Protection and Market Protection Act would direct the Food and Drug Administration to outline a clear federal regulatory framework for hemp and hemp-derived products, promoting consumer safety.

The retail community is making clear that it stands ready to assist recently inaugurated President Joe Biden combat the spread of COVID-19 and get the country vaccinated.

Dr. Rachel Levine, who currently serves as health secretary for the Commonwealth of Pennsylvania, would be the first openly transgender federal official confirmed by the Senate. 

The “4 Things to Know” series features CRN experts offering concise explanations of topics that are central to the supplement industry. 

Supreme court.

The Supreme court ruled 8-0 that an Arkansas law prohibiting PBMs from reimbursing pharmacies at a lower rate than what the pharmacies pay to fill prescriptions is valid and not preempted by the federal Employee Retirement Income Security Act of 1974.

NACDS said it would be offering an interactive exhibit booth and one-on-one meetings for the duration of the National Association of Medicaid Directors’ 2020 Virtual Conference: Together Towards the Future.

The Regulatory Roadmap for the CBD Industry conference is slated for Oct. 21, with various moderators who will participate in a Q&A with the CEO of The Natural Products Association, Daniel Fabricant.

Trump’s executive order will require the government to develop a list of essential medicines and medical supplies from U.S. companies to buy.

President Donald Trump issued four executive orders Friday, largely focused on bringing down drug costs, which split the industry in terms of reactions.

The INFORM Consumers Act targets organized retail crime and would shed light on certain sellers by requiring online retailers to verify high-volume sellers.

The Food and Drug Administration has requested that manufacturers withdraw all prescription and OTC ranitidine drugs from the market immediately.

A new bill introduced by Sens. Bill Cassidy, R-La., and Dick Durbin, D-Ill., focused on improving transparency around third-party sellers online, is getting the backing of Walgreens.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for epilepsy, the agency said Monday.

The FDA announced the approval of Eisai's Fycompa (perampanel) tablets to treat partial-onset seizures in patients ages 12 years and older. Partial seizures are the most common type seen in people with epilepsy, according to the FDA.

Show More